Keyphrases
Malignancy
100%
Meta-analysis
100%
Enterobacteriaceae
100%
Systematic Meta-analysis
100%
Bloodstream Infection
100%
Extended-spectrum-lactamase
100%
ESBL-PE
100%
Resistant Infection
28%
Pooled Prevalence
28%
Inclusion Criteria
14%
Europe
14%
Infection Rate
14%
Solid Tumors
14%
In(III)
14%
PubMed
14%
Embase
14%
Empiric Antimicrobial Therapy
14%
Geographic Region
14%
South America
14%
Annual Increase
14%
Antimicrobial Stewardship
14%
Infected Cases
14%
South-East Asia
14%
Eastern Mediterranean Region
14%
Patients with Hematological Malignancies
14%
Temporal Difference
14%
Gram-negative Bloodstream Infections
14%
Duplicate Report
14%
Western Pacific Region
14%
Medicine and Dentistry
Cancer
100%
Meta-Analysis
100%
Systematic Review
100%
Enterobacteriaceae
100%
Penicillinase
100%
Bloodstream Infection
100%
Extended Spectrum Beta Lactamase
85%
Prevalence
57%
Infection
28%
Hematologic Malignancy
14%
Antiinfective Agent
14%
Infection Rate
14%
Solid Malignant Neoplasm
14%
Antimicrobial Therapy
14%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
14%
Nursing and Health Professions
Systematic Review
100%
Meta Analysis
100%
Bloodstream Infection
100%
Penicillinase
100%
Extended Spectrum Beta Lactamase
100%
Prevalence
57%
Infection
28%
Infection Rate
14%
Medline
14%
Antimicrobial Therapy
14%
Antimicrobial Stewardship
14%
Hematologic Malignancy
14%
Solid Malignant Neoplasm
14%
Pharmacology, Toxicology and Pharmaceutical Science
Enterobacteriaceae
100%
Penicillinase
100%
Bloodstream Infection
100%
Extended Spectrum Beta Lactamase
85%
Prevalence
57%
Infection
28%
Hematologic Malignancy
14%
Infection Rate
14%
Solid Malignant Neoplasm
14%
Antiinfective Agent
14%
Antimicrobial Therapy
14%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
14%
Immunology and Microbiology
Prevalence
100%
Enterobacteriaceae
100%
Infection Rate
25%
Medline
25%
Extended Spectrum Beta Lactamase Producing Enterobacteriaceae
25%